News Article | May 4, 2017
Automated ticketing and mobility surveys by capturing multi-modal travel behaviour How to make public transport even more comfortable for passengers? Can ticketing be simplified? How to capture the actual mobility behavior? Public transport needs to be as efficient and comfortable as possible in order to be attractive for passengers and cost-effective for public transport operators. AIT addresses these challenges with its technology Travel Mode Identification (TMI), which is an innovative software solution automatically identifying travel modes of people carrying a smartphone. The technology can easily be integrated in existing smartphone-apps and automatically classifies eight different travel modes, no user intervention is required. Possible applications are e.g. simple and reliable mobility surveys and novel solutions for automated ticketing. Mobility Surveys Mobility surveys use to be a tremendous effort regarding both, cost and time. So far reams of questionnaires either in writing or by telephone had to be answered and analyzed. Not with TMI: The technology allows collecting data simply via smartphone at lower cost, in less time and higher quality. For this specific application AIT has launched the service "AIT Smart Survey" that has already been applied in several surveys e.g. in Vienna. Automated Ticketing TMI can also be used for integrated mobile ticketing apps for public transport: The technology detects whenever a smartphone user travels on public transport; detailed route information and fees can be calculated accordingly. This offers a maximum level of comfort to the passenger, who does not need to buy any ticket or press any button - it just works automatically. The public transport operator benefits from the fact, that no additional infrastructure - e.g. Bluetooth or Wifi networks - is required, which saves a lot of cost. Next show up UITP Global Public Transport Summit in Montréal/Canada 15 - 17 May 2017 AIT booth: # 2D100 https://uitpsummit.org/exhibitors/ait-austrian-institute-of-technology-gmbh/ About AIT The AIT Austrian Institute of Technology is Austria's largest non-university research institute. With its eight Centers, AIT regards itself as a highly specialised research and development partner for industry. Its researchers focus on the key infrastructure issues of the future: Energy, Health & Bioresources, Digital Safety & Security, Vision, Automation & Control, Mobility Systems, Low-Emission Transport, Technology Experience and Innovation Systems & Policy. Throughout the whole of Austria - in particular at the main locations Wien Tech Gate, Wien TECHbase, Wien Muthgasse, Seibersdorf, Wiener Neustadt, Ranshofen and Leoben - around 1,300 employees carry out research on the development of those tools, technologies and solutions that will keep Austria's economy fit for the future in line with our motto "Tomorrow Today". Contact: Juliane Thoß Marketing and Communications AIT Austrian Institute of Technology Center for Low-Emission Transport Center for Mobility Systems T +43 (0)50550-6322 email@example.com | www.ait.ac.at A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/f4a3b481-b86f-493d-8e86-f8ac20fa334e A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/98b44314-4bb3-490a-9f6d-60b29fcd32eb
News Article | May 4, 2017
4NG takes up the baton from 4energy! 4NG Limited, the Next Generation Industrial IoT “Internet of Things” company, has acquired SMARTset and SMARTstation IoT and other assets of 4energy Limited, together with investment from experienced industry participants including Foster Environmental Limited, Upnorth Group Limited and AIT Partnership Group Limited. This new partnership will enable 4NG to roll out SMARTset software and SMARTstation hardware to the UK and international markets. SMARTset provides operational managers the tools to connect to any equipment, sensor or element of their built environment, irrespective of its protocol or vendor. It can analyse, predict, discover insights and centrally control remote equipment as well as provide first-class alarms and alerts. According to 4NG Managing Director & founder Steve O’Hara “There is great potential for SMARTset & SMARTstation across technical estates: data centres, communication rooms, street furniture and the industrial built environment for SME’s. Our investors have strong relationships with customers in these sectors which will help drive the expansion of 4NG.” Speaking on behalf of the new investors, Steven Bailey comments “We are all excited to join Steve O’Hara and the team on this journey. The customer benefits of the SMARTset and SMARTstation products are clear and we look forward to working closely with 4NG to bring their solution to customers in the UK and overseas”. AIT provides technical services and solutions for data centre management including data centre build and design, power and environmental monitoring systems and DCIM software integration; and secure networks from wireless networks and firewalls to point-to-point microwave radio links. Founded over 15 years ago AIT is a trusted advisor to some of the world’s largest organisations, with a passion for delivering innovation and excellent service and support. Foster Environmental experience in heating, ventilation, air conditioning (HVAC) and refrigeration spans four decades. Our fully trained and dedicated team has amassed an extensive breadth of industry knowledge across every element of heating, ventilation and air conditioning for commercial and industrial environments. We have also developed particular specialism in providing close control mechanical plant and associated electrical services to live technical data centres. Our turnkey solution for data centres, from the cooling plant and controls through to the IT network infrastructure, includes electrical power and lighting, hot and cold aisle containment, BMS, DCIM, fire suppression, life safety and security systems. Building Service Engineers who specialise in all aspects of Critical Facility Engineering. Particularly for the Data Centre and Telecommunications Sector in the UK & Ireland. We specialise in Infrastructure services and can assist you nationwide with design, consulting, optimisation, compliance, service, project plans and new build facilities.
News Article | June 14, 2017
REHOVOT, Israel and NEW YORK, June 14, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical stage anti-microbial therapeutic company treating respiratory diseases with nitric oxide (NO), today announced the appointment of Steve Lisi as Chief Executive Officer, effective June 14, 2017. Mr. Lisi is currently Chairman of the Board. Amir Avniel, the current CEO and a founder, will transition to become President and Chief Operating Officer of the company. “2017 will be a transformative year for AIT Therapeutics and I am thrilled to be appointed CEO at this important time,” said Mr. Lisi. “We have already successfully completed a reverse merger, raised gross proceeds of $10.9 million in an equity offering and our stock is now trading on the Nasdaq OTC marketplace. Our vision is to make our proprietary NO formulation and device an effective treatment for multiple lung infections and diseases. We expect to report Phase 2 data in nontuberculous mycobacteria (NTM) in the fourth quarter of 2017 and Phase 3 data in bronchiolitis (RSV) exacerbations requiring hospitalizations in the first quarter of 2018. I believe that AIT has the potential to deliver significant value while positively impacting the lives of patients. I look forward to working with AIT's executive team and Board to advance the company further." “On behalf of the board, we are very pleased that Amir Avniel will assume an ongoing leadership role at AIT as President and COO, building on his important accomplishments to date,” continued Mr. Lisi. Mr. Lisi has extensive executive management and investment experience covering the life sciences industry. Since 1995 he has been involved with investing in private and public healthcare companies ranging from $2 million to $300 billion in market capitalization. He has been a director of AIT Therapeutics since January 2017 and was appointed Chairman of the Board in May 2017. He previously served as Senior Vice President of Business and Corporate Development at Flamel Technologies (renamed Avadel Pharmaceuticals – AVDL) where he restructured the company and transformed it from $100 million in enterprise value to $1 billion in three years. Prior to his position with Flamel, Mr. Lisi held positions as an analyst at Mehta and Isaly (now OrbiMed) and a portfolio manager at SAC Capital, Millennium Partners, and Deerfield Management. Mr. Lisi is the Co-Founder and Chairman of the Board of Mico Innovations, a next-generation novel bare metal stent company and a board member of Incysus, Ltd., a leading-edge immunotherapy company targeting solid tumors. Mr. Lisi received a Master in International Business from Pepperdine University. About AIT Therapeutics Inc. AIT Therapeutics Inc. is a clinical-stage anti-microbial therapeutic company developing novel non-antibiotic anti-microbial therapeutics for respiratory diseases based on nitric oxide (NO) as well as other indications. The Company is applying its therapeutic expertise to prevent and treat lower respiratory tract infections, many of which cannot effectively be addressed with current standards of care. AIT Therapeutics is advancing its revolutionary respiratory targeted system in a pipeline of clinical trials for the treatment of bronchiolitis (RSV) exacerbations, and nontuberculous mycobacteria (NTM). For more information, visit www.AIT-Pharm.com. Forward-Looking Statements This press release contains “forward-looking statements”. Forward-looking statements include statements about our expectations, beliefs or intentions regarding our product offerings, business, financial condition, results of operations, strategies or prospects. You can identify such forward-looking statements by the words “expects,” “intends,” “plans,” “projects,” “believes,” “estimates,” “likely,” “goal,” “assumes,” “targets” and similar expressions and/or the use of future tense or conditional constructions (such as “will,” “may,” “could,” “should” and the like) and by the fact that these statements do not relate strictly to historical or current matters. Rather, forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause our actual results to differ materially from any future results expressed or implied by the forward-looking statements. These forward-looking statements are only predictions and reflect our views as of the date they are made with respect to future events and financial performance. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including risks related to: our approach to discover and develop novel drugs, which is unproven and may never lead to marketable products; our ability to fund and the results of further pre-clinical and clinical trials; obtaining, maintaining and protecting intellectual property utilized by our products; our ability to enforce our patents against infringers and to defend our patent portfolio against challenges from third parties; our ability to obtain additional funding to support our business activities; our dependence on third parties for development, manufacture, marketing, sales, and distribution of products; the successful development of our product candidates, all of which are in early stages of development; obtaining regulatory approval for products; competition from others using technology similar to ours and others developing products for similar uses; our dependence on collaborators; and our short operating history. We undertake no obligation to update, and we do not have a policy of updating or revising, these forward-looking statements, except as required by applicable law.
News Article | June 15, 2017
REHOVOT, Israel and NEW YORK, June 15, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical stage anti-microbial therapeutic company treating respiratory diseases with nitric oxide (NO), today announced that Steve Lisi, Chief Executive Officer, will conduct investor meetings at the JMP Securities Life Science Conference, taking place on June 20-21, 2017 in New York City. About AIT Therapeutics Inc. AIT Therapeutics Inc. is a clinical-stage anti-microbial therapeutic company developing novel non-antibiotic anti-microbial therapeutics for respiratory diseases based on nitric oxide (NO) as well as other indications. The Company is applying its therapeutic expertise to prevent and treat lower respiratory tract infections, many of which cannot effectively be addressed with current standards of care. AIT Therapeutics is advancing its revolutionary respiratory targeted system in a pipeline of clinical trials for the treatment of bronchiolitis (RSV) exacerbations, and nontuberculous mycobacteria (NTM). For more information, visit www.AIT-Pharm.com.
News Article | February 23, 2017
Vienna, 23.02.2017 The key to a well-designed airport is to understand how passengers interact with their environment and how visual information influences their orientation and navigation behavior. Of particular importance is wayfinding information, which often competes with other visual stimuli such as advertising. Wayfinding has to be an integral part of the design process to create more intuitive architectural spaces where passengers navigate instinctively. Evaluating the design from a passenger's wayfinding perspective already in the planning phase can prevent wrong design choices which might result in higher costs at later stages. EXPERIENCE is a consulting service based on virtual reality technologies which offers a novel method for an interactive exploration and analysis of architectural models and designs before they are built. It uses a test environment allowing persons to walk through virtual 3D models of airports while measuring their movement, visual attention and relevant behavioral characteristics. For a high level of realism, EXPERIENCE combines immersive visual computing technologies, characteristic soundscapes and cutting-edge crowd simulations - based on the framework SIMULATE, which is also used for evacuation and capacity analysis of infrastructures. As a result, the passenger wayfinding experience can be evaluated by quantifying several passenger-oriented aspects (detailed passenger-route-analysis, visibility of static and dynamic signage, etc.) in customized scenarios with a representative cross-section of user groups (age, nationality, etc.). EXPERIENCE was developed by experts from the AIT Austrian Institute of Technology Center for Mobility Systems in close cooperation with Fraunhofer Austria Research GmbH. This collaboration enabled the development of an ideal solution for architects, operators of large infrastructures and public spaces, transportation planners and consultants. It effectively supports the evaluation of architecture and identifies issues ahead of time, resulting in reduced need for re-work and project cost savings. As such it revolutionizes wayfinding planning processes and enables to test the acceptance of the terminal visibility as a whole or of its subsystems and components. EXPERIENCE improves pedestrian flows - as well as the performance of designs - and increases customer satisfaction leading to greater usage and turnover. EXPERIENCE was successfully used in the planning phase of Vienna's new Central Railway Station to improve the guidance of people through the facility. How to find us at Passenger Terminal Expo 2017: AIT Austrian Institute of Technology GmbH Hall 8, Booth 5100 Contact: Silvia Bernkopf, +43 664 8251470 About AIT The AIT Austrian Institute of Technology is Austria's largest non-university research institute. With its eight Centers, AIT regards itself as a highly specialised research and development partner for industry. Its researchers focus on the key infrastructure issues of the future: Energy, Health & Bioresources, Digital Safety & Security, Vision, Automation & Control, Mobility Systems, Low-Emission Transport, Technology Experience and Innovation Systems & Policy. Throughout the whole of Austria - in particular at the main locations Wien Tech Gate, Wien TECHbase, Wien Muthgasse, Seibersdorf, Wiener Neustadt, Ranshofen and Leoben - around 1,300 employees carry out research on the development of those tools, technologies and solutions that will keep Austria's economy fit for the future in line with our motto "Tomorrow Today". Contact: Juliane Thoß Marketing and Communications AIT Austrian Institute of Technology Center for Low-Emission Transport Center for Mobility Systems T +43 (0)50550-6322 firstname.lastname@example.org | www.ait.ac.at
News Article | December 22, 2016
Based in Lynnwood, WA, Nova-Tech is a designer and integrator of critical assembly automation, materials handling and friction stir welding equipment and tooling for the aerospace and space launch industries. Nova-Tech’s talented engineering and executive team will join the AIT family while continuing to operate as a distinct business line and brand led by Nova-Tech’s CEO, William B. (“Benny”) Teal. “In our industry, Nova-Tech is synonymous with engineering excellence and dedicated customer service,” said Ed Chalupa, AIT’s Chairman and CEO. “Benny and his team have established a culture that perfectly exemplifies the entrepreneurship and innovation that has always driven the aerospace industry forward. Nova-Tech’s strong presence in international markets and adjacent sectors like space launch is particularly unique in our industry.” “The adoption of automation in aerospace is accelerating, just as the automation supply base is consolidating offshore,” said Teal. “It’s exciting to have a partner in this environment and to be a part of a platform with this scale of technology and engineering talent.” AIT’s investment in Nova-Tech represents its second transaction in the aerospace automation sector following the purchase earlier this month of KUKA Systems Aerospace North America (as recently reorganized) in a carve-out transaction from KUKA Systems North America LLC. The financial terms of the transaction were not disclosed. AIT is the world's largest provider of automation, factory integration and tooling solutions dedicated to the global aerospace and defense industries. From its headquarters in Plano, Texas, AIT designs, manufactures and installs automated tooling and equipment for the assembly of aerospace structures. AIT serves the world’s largest and most technologically advanced aerospace OEMs and Tier 1 suppliers, including Boeing, Airbus, Lockheed Martin, Northrop Grumman, Spirit AeroSystems, Triumph and Bombardier. AIT has facilities in the United States, Canada, Spain and Sweden. Nova-Tech is in its forty-eighth year and is well established as a premier supplier of manufacturing solutions to the worldwide aerospace industry. Headquartered in Lynnwood, Washington, it also has offices in South Carolina, Alabama, Germany, Brazil and the U.K. The company serves all the major commercial aircraft manufacturers, and is also engaged with defense work and space launch vehicles.
AIT Inc | Date: 2016-01-29
A method for monitoring medication intake activity comprising receiving patient data, receiving prescription data, receiving drug data, receiving risk element data and calculating, by a processor, a patients risk level for abusing controlled substances based on the drug data, the prescription data, the risk element data, and the patient data
News Article | December 8, 2016
SINGAPORE, BEIJING, and SAN DIEGO, Dec. 8, 2016 /PRNewswire/ -- Novogene, a leading commercial provider of genomic services and solutions with cutting edge next-generation sequencing and bioinformatics expertise; AITbiotech Pte Ltd, a Singapore biotechnology company; and the Genome...
News Article | May 25, 2015
Sundays have a way of being languid. You could be recovering from a hangover induced by the previous night’s binge. Or, you went to church, if such was your convention. Or you sat in your house and watched television – if there was power supply, whether from the national grid or from your generator. As the day wore on, you decided if, perhaps, there was some wisdom in paying someone a visit; alternatively, you accepted the fait accompli of a few folks, including disagreeable ones, looking in and setting you back by a few coins, thanks to the booze you would offer them. After the sun had withdrawn the sharper pricks of its burning fire, you could settle for watching on the silver screen as soccer stars justified their hefty paychecks and perquisites in the leagues of foreign countries. Whether the final scores gave you cheer or pain, both of which emotions should actually be pointless for the Nigerian, you watched the day gently slip away. You looked up to Monday morning, if you aren’t of the countless unemployed, that is. On Sunday, April 19, the evening caught me with not much to do. I didn’t see the point of venturing out. I would, whether or not I liked it, leave home to following day, to keep a 10am appointment. It was necessary to print out the 40 something pages of text I had written, so we chat over their import and chart the course of further work. I kept the printed pages on a side table and took to my bed, not to go to sleep at 5.30 pm, but to sate my rediscovered joy of reading Albert Camus, whose book of essays, The Myth of Sisyphus, I had handy. I hadn’t done an hour of reading when my phone rang. It was the same lady who had broken the news of General Emeka Ojukwu’s death to me in 2011. “Are you watching AIT?” She asked. I wasn’t watching anything, I replied. My TV wasn’t even on. “Switch it on and tune to AIT.” I told her I wasn’t prepared to do anything of the sort, unless she mentioned whatever awaited my confrontation. Thus, when I got to Comrade Uche Chukwumerije’s Maitama, Abuja home on April 20, it was not for us to look at the draft of two more chapters of his biography that I had written. Once I entered the house, Chika, the Olympic taekwondo champion, and one of Chukwumerije’s six sons, welcomed me with a handshake and this declaration: “Your friend is dead.” Although I had known of him since Biafra, my friendship with Chukwumerije started in 2000. That year, I had presented him with a copy of Ironside, my biography of General Aguiyi-Ironsi and, although it was rather presumptuous of me (not by any stretch of the imagination would anyone pretend that I and the comrade were transmitting from the same megahertz; he was up there and I was groping for the ropes with which to climb) I asked if he would please do a review of the book for its Enugu presentation. Chukwumerije gladly accepted the task. I believe it was Ironside that persuaded him years later to commission me to write his own biography. But the going wasn’t easy. He was busy at the Senate, and I held down the job of Chief of Staff to the Governor of Anambra State. Years later, when I had turned my back to the Awka political establishment, I returned to him with apologies on the slow pace of work on the biography. But he would not hear of it, insisting that nobody was to blame since we both had our hands full of other pressing responsibilities. Months later, I visited him one evening and watched with a certain alarm as he belaboured me for tardiness on the project. But, in a certain sense, Chukwumerije was a strange man. He didn’t dwell on infractions against his person. For instance, and as I found out in the course of my research, one of his half-brothers, an undergraduate, who was on vacation in his Lagos home, had decided that he had better use of Chukwumerije’s wristwatch. Chukwumerije found out, recovered the watch and instantly forgot the matter. Chukwumerije was easy to misunderstand because he was an epitome of bluntness; but innately, he was a most considerate and sensitive mind. He made a choice early in life to stand on the side of the downtrodden. He was a revolutionary who changed his mind at the last moment against embarking on a military career, deciding instead to fight his cause with the weapon of mass communication. He was an accomplished broadcaster and journalist. That was why, shortly after the civil war, he established Afriscope, an international monthly that mediated global developments from a purely African perspective. He had been a member of the Socialist Workers and Farmers Party (SWAFP) during the First Republic, and was one of the leaders of the left-leaning People’s Redemption Party (PRP) in the Second Republic. But two of the most important roles he played were (1) in Biafra, where he was directed the secessionist republic’s propaganda machinery, and (2) in the Interim Government of Ernest Shonekan in which he was Information Secretary. A good many of the views held on this man are tied to those epochs, but they tell far less than the entire story of his reason-induced and action-packed years. A few days ago, I got shown streams of an Internet conversation on Chukwumerije by Nigerian intellectuals mostly based in the United States. Professor Abiola Irele, the renowned literary critic, observed that, “Uche was a good friend and a great journalist. I wish him good repose.” He got stridently countered by Ebenezer Obadare, an associate professor of Sociology at the University of Kansas: “Thanks Professor Irele. But Senator Chukwumerije was more than that, and for the sake of posterity, it is important that even as we mourn, we continue to see clearly. “The departed senator was a malevolent force against the realization of democracy in Nigeria, and that too ought to be part of his memoriam. He trenchantly stymied the trajectory of a noble cause, and his deeds and misdeeds as the shameless factotum of the Shonekan and Abacha regimes brought grief to many families. “Part of doing justice to the memory of the dead has to be an honest accounting of what they did while alive. “May the senator rest in peece – and may the facts of his public service remain fresh in our memory.” Not surprisingly, Dr. Obi Nwakanma, the poet and Vanguard columnist, who teaches at the University of Central Florida, came to Chukwumerije’s defence: “Ebenezer. Uche Chukwumerije was a great Nigerian patriot who defended the interests of Nigeria as he saw it against imperialism by radical means. His work as a nationalist politician, from his days at the University College Ibadan, to his association with Otegbeye’s and Nzimiro’s Socialist Workers Party, and as Secretary-General of the PRP under the leadership of Mallam Aminu Kano in the Second Republic, and his service, his last hurrah as a senator of the republic who used his position in the Senate Education Committee to work for greater funding, particularly for Nigeria’s public universities, puts him beyond the pale of your characterization of him. It is often said that those who merely play drums for the Ijele on the side do not know the real toll it takes on the Ijele to carry the great mask. “Uche Chukwumerije did not oppose the June 12 mandate, he opposed the violation of Nigeria’s sovereignty by those who find easy comfort in urging the external invasion of Nigeria. He is a greater patriot than those who will, in the end live more in infamy than to question the true patriots who have put their feet on the ground for Nigeria, and have the marks to show for it. May Chukwumerije find rest. He is in the end, to be counted among the immortals of Nigeria.” In my view, the antipodal positions of Obadare and Nwakanma represent the tension that the biography I am working on must mediate. I may just add that Obadare’s invective is not outrageous. It is just too simply. But its simplicity is understandable, since it issues from this Age of Brevity where the social media not only allows but also actively promotes a brand of laziness that discourages the detailed exploration of antinomies. Really, it makes uncomplimentary remarks about the intellection of a people who experienced the profundity of the Nigerian civil war but have never really made any honest attempts at studying and fully appreciating its particularities and ramifications. That was why the publication of Chinua Achebe’s There Was A Country elicited from quarters thought to be academic more heat than light. That is also why, in recent weeks, all sorts of voices, including those of traditional rulers and medical doctors, have been in ascent, advocating yet another anti-Igbo pogrom. If Nigerian leaders are to be believed, the civil war was fought to keep Nigeria one. But what has continued to happen since the cessation of hostilities in January 1970, is the systematic consignment of the Igbo to a level worse than that of fourth-class citizens. In the 1979 general elections, there were five presidential candidates, one of whom was Dr. Nnamdi Azikiwe, an Igbo. And there were five vice-presidential candidates, four of whom were Igbo. In less than four decades, the condition of Ndigbo have, in a Nigeria ostensibly kept “one”, degenerated to a lack of right to live or school or work or trade in Lagos. They can’t even aspire to produce a Minister of the Federal Capital Territory of Abuja. They must spend the rest of their lives looking behind their backs, less they are caught unawares and massacred again in a fresh wave of ethnic cleansing. Comrade Uche Chukwumerije belonged to the fearless cadre of those loudly protesting that the current political status quo is a recipe for keeping Nigeria, not one, but two or many more. It is on this adamantine insistence on the imperative of justice and equity that his larger-than-life patriotic heroism is indexed.
News Article | May 27, 2015
An Ikeja High Court in Lagos on Wednesday adjourned a N150 billion libel suit filed by former Lagos State Governor, Asiwaju Bola Tinubu, against the African Independent Communication (AIT) till June 30. Justice Iyabo Akinkugbe adjourned the suit to enable Tinubu’s counsel respond to the counter-claim filed by AIT. Recall that Tinubu had instituted the suit against Daar Communications Plc, owners of AIT, for airing a documentary entitled, “Lion of Bourdilion”. In the suit, he alleged that the documentary, which started airing on March 1, was libelous and aimed at tarnishing his image. At the resumption of proceedings on Wednesday, AIT’s counsel, Mr Jeffery Kadiri, informed the court that the defendant had filed a counter-claim which had been served on the claimant. Responding, Tinubu’s counsel, Mr Ayodele Adedipe, said that the process was served on the claimant only two days ago, adding that he needed time to respond. Adedipe, therefore, asked the court for an adjournment and the judge acceded to his request. In the counter-claim, AIT listed its Chairman emeritus, Chief Raymond Dokpesi and seven others as witnesses to testify against Tinubu. Others listed to testify are : Namure Edoimioya, Chief Medan Tenke, Ajibola Adewusi, Olumide Idowu, Chief Stanley Odidi, Nwabueze and Dr Stanley Bassey. The broadcast outfit also denied each and every allegation of facts as contained in the claimant’s amended statement of claim. Dokpesi, in his statement on oath, averred that Tinubu’s claim was founded on none existing ground, because the said documentary was not entitled “The Lion of Bourdilon,” but “Unmasking the Real Tinubu”. He also averred that the documentary, in his honest opinion, was not false and was not aired out of malice to the person of the claimant. Dokpesi said that AIT, as a member of the fourth estate of the realm, was empowered by Section 22 of the Constitution to at all times, hold those in government accountable and responsible to the people of Nigeria. He further averred that the contents of the documentary were facts which had been in the public domain for over two decades. According to him, these are published independently, prior to the broadcast and have remained unchallenged till date.